Home/Filings/4/0001273636-19-000010
4//SEC Filing

Feinsod Matthew 4

Accession 0001273636-19-000010

CIK 0001273636other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 4:21 PM ET

Size

6.1 KB

Accession

0001273636-19-000010

Insider Transaction Report

Form 4
Period: 2019-05-13
Feinsod Matthew
Interim Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-05-13+2,00054,014 total
  • Tax Payment

    Common Stock

    2019-05-13$4.20/sh685$2,87753,329 total
Footnotes (1)
  • [F1]The common stock vested immediately upon grant.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001716950

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:21 PM ET
Size
6.1 KB